Skip to main content

US ClosedU.S. Closed

RLMD: Relmada Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States.

52W Range

47thpctl

Volume

0.44×avg

Market Cap

454.17MUSD

P/E Ratio

-4.7TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Relmada Therapeutics, Inc.

RLMDNASDAQ·USD·Closed

Relmada Therapeutics, Inc.

RLMDNASDAQ·USD·Closed

$4.33

−4.20%

$4.33

−$0.19 (4.20%)

52W Range

47thpctl

Volume

0.44×avg

Mkt Cap

454.17MUSD

P/E

-4.7TTM

Div Yield

–ann